DALLAS, June 8, 2007 (PRIME NEWSWIRE) -- John Pentony, Publisher of StockGuru.com, announced today that the web site has initiated Profile Coverage of Biotech Holdings Ltd. (OTCBB:BIOHF) (TSX-V:BIO). Biotech Holdings is a pharmaceutical production and distribution company based in Vancouver, Canada. The company has developed an important new anti-diabetic medication, which has been trademarked as "Sucanon" and "Diab II". Biotech is now focused on the distribution and marketing of this medication. The Company also looks forward to the development of combination therapies using this new proprietary medication in combination with other well-established treatments for Type II Diabetes, which is one of the world's most widespread and rapidly growing diseases.
Sucanon has been proven effective in clinical trials. The drug has been approved by regulatory authorities in Mexico and is widely sold in that country including by Costco Mexico and Wal-Mart Mexico. Sucanon is also available by internet to Type II Diabetics in North America and elsewhere who are buying for personal use.
To view the StockGuru.com Profile for Biotech Holdings Ltd., please visit: http://www.stockguru.com/profiles/biohf
About StockGuru.com
StockGuru.com features daily alerts going out three times daily to members. To join our email alert list, please visit:
http://www.stockguru.com/stocks.htm
To feature your publicly traded company in our alerts, or to discuss our complete services, please contact: John Pentony at (469) 252-3031 or email publisher@stockguru.com. Our services include our Morning, Midday, and After The Bell news releases. Additionally, we profile publicly traded companies on our web site, we do interviews with CEOs or other key executives on our web site, and we have our financial writers cover our companies.
Any statements made in this release that are not based on historical fact are forward-looking statements. Any forward-looking statements made in this release represent management's best judgement as to what may occur in the future. However, actual outcome and results are not guaranteed and are subject to certain risks, uncertainties and assumptions and may differ materially from what is expressed.
Disclosure: Pentony Enterprises LLC has been compensated $30,000 from a non-controlling third party for profile coverage. Pentony Enterprises is not a registered investment adviser or a broker/dealer. Pentony Enterprises LLC makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.